John Laterra

5PUBLICATIONS
32CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 08, 2026
Phase Ia Evaluation of LP-184 in Recurrent Glioblastoma: Safety, Pharmacokinetics, and Translational Optimization of CNS Exposure.

|Apr 17, 2026
Ivosidenib and Vorasidenib Decrease Intratumoral 2-Hydroxyglutarate and Total Choline Levels in Patients with Lower-Grade Glioma: An In Vivo MR Spectroscopy Study.

|Jul 26, 2023
Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma.

Bachchu Lal, Aditya Kulkarni, Joseph McDermott

|Jun 29, 2023
Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase-mutant Astrocytic and Oligodendroglial Tumors.

David Olayinka Kamson, Sushant Puri, Yingying Sang

Pageof 1

Frequent Collaborators

2 joint publications

David Olayinka Kamson

2 joint publications

Matthias Holdhoff

2 joint publications

Kishor Bhatia

2 joint publications

Lindsay Blair